Treatment of resistant eczematous dermatoses with a new compound, fluocinolone acetonide.
D003872:Dermatitis; D012628:Dermatitis, Seborrheic / Q000628:therapy*; D004485:Eczema / Q000628:therapy*; D005446:Fluocinolone Acetonide; D006801:Humans; D011239:Prednisolone / Q000031:analogs & derivatives; D017443:Skin Diseases, Eczematous
D005446:Fluocinolone Acetonide; D011239:Prednisolone
ECZEMA/therapy; PREDNISOLONE/related compounds; SEBORRHEA/therapy